Skip to main content
. 2020 May 20;7(4):1409–1418. doi: 10.1002/ehf2.12750

Table 4.

Baseline echocardiography and clinical characteristics of MitraClip patients according to reverse remodelling (reduction of 10% of LVESV)

Baseline clinical and echocardiography data ΔLVESV >10% ΔLVESV <10% P value
Log EuroSCORE (%) 21.3 ± 13.4 27 ± 17.6 0.273
BNP (pg/mL) 1115 ± 1324 853 ± 738 0.471
NYHA Class 3.1 ± 0.7 3.2 ± 0.5 0.339
6MWD (m) 232 ± 143 257 ± 147 0.599
Dilated cardiomyopathy (%) 35 ± 49 31 ± 47 0.783
GLS (%) −9.2 ± 4.6 −8.0 ± 2.9 0.369
LVEDV (mL) 232 ± 72 209 ± 77 0.1
LVESV (mL) 164 ± 68 140 ± 66 0.12
EF (%) 32 ± 10 31 ± 8 0.750
EROA (mm2) 35 ± 21 27 ± 12 0.132
GWI (mmHg%) 706 ± 392 568 ± 187 0.07
GCW (mmHg%) 1011 ± 343 762 ± 206 0.002
GWW (mmHg%) 131 ± 71 123 ± 62 0.797
GWE (%) 79 ± 10 81 ± 10 0.656

ΔLVESV is the reduction of 10% of LVESV (upper tercile of the study cohort).

EF, ejection fraction; EROA, effective regurgitant orifice area; GCW, global constructed work; GLS, global longitudinal strain; GWE, global work efficiency; GWI, global work index; GWW, global wasted work; LA, left atrial; LVEDV, left ventricular end diastolic volume; LVESV, left ventricular end systolic volume; MR, mitral regurgitation; PALS, peak atrial longitudinal strain.